These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 11794352)

  • 41. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacy directors fear that anti-resale law may be point of no return for drugs.
    Wagner M
    Mod Healthc; 1988 Sep; 18(40):38. PubMed ID: 10290435
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 44. Information search activities among elderly prescription drug users.
    Morris LA; Grossman R; Barkdoll G; Gordon E; Chun MY
    J Health Care Mark; 1987 Dec; 7(4):5-15. PubMed ID: 10285778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 47. Bill may curb physician's right to prescribe.
    Harvey MW; Keller SE
    Leg Aspects Med Pract; 1978 Sep; 6(9):27-30. PubMed ID: 750818
    [No Abstract]   [Full Text] [Related]  

  • 48. A brief history of 180-day exclusivity under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act.
    Lietzan EK
    Food Drug Law J; 2004; 59(2):287-323. PubMed ID: 15298013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Orphan Drug Act: an engine of innovation? At what cost?
    Rohde DD
    Food Drug Law J; 2000; 55(1):125-43. PubMed ID: 12322720
    [No Abstract]   [Full Text] [Related]  

  • 50. Rx: Canadian drugs.
    Zuger A
    N Engl J Med; 2003 Dec; 349(23):2188-90. PubMed ID: 14657425
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 52. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 54. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 55. Mail-order sales of drugs without prescriptions under investigation by US, Canadian agencies.
    Spurgeon D
    CMAJ; 1993 Dec; 149(11):1700-1. PubMed ID: 8242510
    [No Abstract]   [Full Text] [Related]  

  • 56. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacy compounding: customizing prescription drugs.
    Nordenberg T
    FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628
    [No Abstract]   [Full Text] [Related]  

  • 58. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 59. FDA warns about fraudulent STD treatments.
    AIDS Patient Care STDS; 2008 Apr; 22(4):353. PubMed ID: 18434953
    [No Abstract]   [Full Text] [Related]  

  • 60. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.